LOBEF (Lobe Sciences) Total Stockholders Equity : $-2.62 Mil (As of Feb. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Lobe Sciences Total Stockholders Equity?

Lobe Sciences's Total Stockholders Equity for the quarter that ended in Feb. 2025 was $-2.62 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Lobe Sciences's Book Value per Share for the quarter that ended in Feb. 2025 was $-0.01. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Lobe Sciences's Debt-to-Equity for the quarter that ended in Feb. 2025 was -0.58.

Lobe Sciences Total Stockholders Equity Historical Data

The historical data trend for Lobe Sciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences Total Stockholders Equity Chart

Lobe Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Total Stockholders Equity

Get a 7-Day Free Trial

9.13

8.96

0.35

-0.12

-2.28

Lobe Sciences Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Total Stockholders Equity	Get a 7-Day Free Trial															-0.92	-0.81	-2.28	-2.48	-2.62

Lobe Sciences (OTCPK:LOBEF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Lobe Sciences's Book Value per Share for the quarter that ended in Feb. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-2.616	-	0)	/	192.652
	=	-0.01

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Lobe Sciences's Debt-to-Equity for the quarter that ended in Feb. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.448	+	1.057)	/	-2.616
	=	-0.58

Lobe Sciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Lobe Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (OTCPK:LOBEF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

LOBE:Canada

Address

1771 Robson Street, No. 1614, Vancouver, BC, CAN, V6G 3B7

Website

https://www.lobesciences.com

Lobe Sciences Ltd is a biopharmaceutical company committed to discovering and developing patient-focused medicines for orphan and rare diseases. It is engaged in drug research and development to improve brain and mental health and wellness. The company plans to commercialize a medical food named Altemia for the treatment of Sickle Cell Disease and has other drugs in pipeline such as L-130 Treatment for Chronic Cluster Headache, L-131 Treatment for Pediatric Anxiety and S-100 Treatment for Sickle Cell Disease.